malignant liver tumors
Conditions
Interventions
Microwave ablation treatment group:NA
Sponsors
China-Japan Union Hospital of Jilin University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Primary liver cancer: percutaneous puncture pathological diagnosis; Diagnosed according to the "Diagnosis and Treatment Standards for Primary Liver Cancer" without pathological patients. Metastatic liver cancer: percutaneous puncture pathological diagnosis; Non pathological patients who meet the diagnosis criteria for metastatic liver cancer in the "Diagnosis and Treatment Standards for Primary Liver Cancer".; (2) The diameter of the lesion is less than 5cm. (3) Liver cancer lesions are suitable for microwave ablation treatment; (4) There is no gender or age limit.
Exclusion criteria
Exclusion criteria: (1) Tumors cannot be completely ablated by microwave in one go; (2) During the study, severe liver and kidney dysfunction, coagulation disorders, and immune system diseases were combined; (3) Received surgery, intervention, radiotherapy, chemotherapy, and immune enhancers within one month before and after ablation treatment; (4) I am currently participating in other clinical studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| heat shock protein 70;heat shock protein 90; | — |
Secondary
| Measure | Time frame |
|---|---|
| Interferon ?;Interleukin 2;Interleukin 6;Interleukin 8;Interleukin 10;Interleukin 12;Interleukin 22;Tumor necrosis factor a;CD3+T cell levels;CD4+T cell levels;CD8+T cell levels; | — |
Countries
China
Contacts
Public ContactGuoqing Sui
China-Japan Union Hospital of Jilin University
Outcome results
None listed